These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21962292)

  • 21. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P; Unger HW; Rogerson SJ; Mola GDL
    Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
    Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
    Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets.
    Kabanywanyi AM; Macarthur JR; Stolk WA; Habbema JD; Mshinda H; Bloland PB; Abdulla S; Kachur SP
    Malar J; 2008 Jul; 7():133. PubMed ID: 18644118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon.
    Mbu RE; Takang WA; Fouedjio HJ; Fouelifack FY; Tumasang FN; Tonye R
    BMC Womens Health; 2014 May; 14():68. PubMed ID: 24886135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas.
    Briand V; Cottrell G; Massougbodji A; Cot M
    Malar J; 2007 Dec; 6():160. PubMed ID: 18053209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
    Chico RM; Chandramohan D
    Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.
    González R; Mombo-Ngoma G; Ouédraogo S; Kakolwa MA; Abdulla S; Accrombessi M; Aponte JJ; Akerey-Diop D; Basra A; Briand V; Capan M; Cot M; Kabanywanyi AM; Kleine C; Kremsner PG; Macete E; Mackanga JR; Massougbodgi A; Mayor A; Nhacolo A; Pahlavan G; Ramharter M; Rupérez M; Sevene E; Vala A; Zoleko-Manego R; Menéndez C
    PLoS Med; 2014 Sep; 11(9):e1001733. PubMed ID: 25247709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
    Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
    Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial.
    Njagi JK; Magnussen P; Estambale B; Ouma J; Mugo B
    Trans R Soc Trop Med Hyg; 2003; 97(3):277-82. PubMed ID: 15228241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
    Odongo CO; Bisaso RK; Byamugisha J; Obua C
    Malar J; 2014 Oct; 13():399. PubMed ID: 25306431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
    van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO
    Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.